Regulatory Considerations DMEG Shares Update on ICH E6(R3) Training Modules Available
Date: October 7, 2026
The ICH Working Groups and The ICH Training Associates have released two new training modules on ICH E6 R3. Both modules incorporate Annex 2 updates.
In September 2026 ICH published Module 5 which focuses on Essential Records and in October 2026 they published Module 3 which focuses on Data Governance.
Module 5 Essential Records contains two sub-modules: 5.1: Essentiality of trial records and 5.2 Management and retention of essential records.
Module 3 Data Governance contains four sub-modules: 3.1 Introduction to Data Governance, 3.2 Risk-proportionate Approach to Data Governance, 3.3 Risk-proportionate Approach to Management of Computerized Systems and 3.4 Data Lifecycle Management.
Explore More News

Regulatory Considerations DMEG Shares Update on ICH E6(R3) Training Modules Available
The ICH Working Groups and The ICH Training Associates have released two new training . . .
Read More

Recent update from the regulatory landscape in clinical data management
On 22 September, MHRA published a new set of inspection dossier documents specifically for . . .
Read More

Regulatory Considerations DMEG Update – August 2026
Please read the following update from the Regulatory Considerations DMEG:
July and . . .
Read More

Get to know ACDM Board Member: Santosh Karthikeyan Viswanathan
We caught up with one of ACDM’s new Board Members, Santosh Karthikeyan Viswanathan, to . . .
Read More

Guidance on Decentralized Clinical Trials to be Reviewed by the ACDM RC DMEG
Health Canada (HC) continues to publish new guidelines to support their modernization of . . .
Read More

Regulatory Considerations DMEG to Review Health Canada’s Draft Guidance
Thank you to the Regulatory Considerations DMEG for sharing this update.
Health Canada . . .
Read More

Recent update from the regulatory landscape in clinical data management
Thank you to the Regulatory Considerations DMEG for sharing this update.
On July 15 the . . .
Read More

Regulatory Considerations DMEG Update – June 2026
Please read the following update from the Regulatory Considerations DMEG:
Regulators have . . .
Read More

FDA Announces New Initiative for Real-Time Clinical Trials
The U.S. Food and Drug Administration (FDA) has announced a new initiative to support the . . .
Read More

Get to know ACDM Board Member Jennifer Duff
We caught up with one of ACDM’s new Board Members, Jennifer Duff, to learn more about her. . . .
Read More

Recent News in Regulatory Landscape
The ACDM Regulatory Considerations DMEG have kindly put together a short news piece . . .
Read More

Real-Time Clinical Data Flow: Why the FDA’s New Pilot Validates the Data Flow Modernization Agenda
Tamer Chowdhury, on behalf of ACDM Technology DMEG.
On April 28, FDA Commissioner Dr. . . .
Read More